Gemina Laboratories Current Ratio vs. Return On Equity
| GLABF Stock | USD 0.57 0.02 3.64% |
For Gemina Laboratories profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Gemina Laboratories to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Gemina Laboratories utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Gemina Laboratories's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Gemina Laboratories over time as well as its relative position and ranking within its peers.
Gemina |
Gemina Laboratories Return On Equity vs. Current Ratio Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Gemina Laboratories's current stock value. Our valuation model uses many indicators to compare Gemina Laboratories value to that of its competitors to determine the firm's financial worth. Gemina Laboratories is rated # 2 in current ratio category among its peers. It also is rated # 2 in return on equity category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Gemina Laboratories' earnings, one of the primary drivers of an investment's value.Gemina Return On Equity vs. Current Ratio
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Gemina Laboratories |
| = | 2.50 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Gemina Laboratories |
| = | -3.47 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Gemina Return On Equity Comparison
Gemina Laboratories is currently under evaluation in return on equity category among its peers.
Gemina Laboratories Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Gemina Laboratories, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Gemina Laboratories will eventually generate negative long term returns. The profitability progress is the general direction of Gemina Laboratories' change in net profit over the period of time. It can combine multiple indicators of Gemina Laboratories, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. It is developing POC Antigen COVID test, a point-of-care lateral flow assay test strip to test whether or not a person is currently infected with COVID-19. Gemina Laboratories operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 5 people.
Gemina Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Gemina Laboratories. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Gemina Laboratories position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Gemina Laboratories' important profitability drivers and their relationship over time.
Use Gemina Laboratories in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Gemina Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gemina Laboratories will appreciate offsetting losses from the drop in the long position's value.Gemina Laboratories Pair Trading
Gemina Laboratories Pair Trading Analysis
The ability to find closely correlated positions to Gemina Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Gemina Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Gemina Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Gemina Laboratories to buy it.
The correlation of Gemina Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Gemina Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Gemina Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Gemina Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Gemina Laboratories position
In addition to having Gemina Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Long Short Funds Thematic Idea Now
Long Short Funds
Funds or Etfs that are designed to hedge away market risk by investing in combination of bonds, stocks, derivative instruments as well as short positions to maximize returns irrespective of market conditions. The Long Short Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Long Short Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Gemina OTC Stock
To fully project Gemina Laboratories' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Gemina Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Gemina Laboratories' income statement, its balance sheet, and the statement of cash flows.